XML 40 R30.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Segment Information (Tables) | 9 Months Ended
--- | ---
Dec. 31, 2015
Segment Reporting [Abstract] |
Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals | Financial information relating to our reportable operating segments and reconciliations to the condensed consolidated totals is as follows:
| Quarter Ended December 31, |  | Nine Months Ended December 31,
(In millions) | 2015 |  | 2014 |  | 2015 |  | 2014
Revenues |  |  |  |  |  |  |
Distribution Solutions (1) |  |  |  |  |  |  |
North America pharmaceutical distribution and services | $ | 39,615 |  |  | $ | 37,397 |  |  | $ | 119,750 |  |  | $ | 106,848 |
International pharmaceutical distribution and services | 6,022 |  |  | 6,767 |  |  | 17,726 |  |  | 20,506 |
Medical-Surgical distribution and services | 1,568 |  |  | 1,565 |  |  | 4,579 |  |  | 4,473 |
Total Distribution Solutions | 47,205 |  |  | 45,729 |  |  | 142,055 |  |  | 131,827 |
Technology Solutions - products and services | 694 |  |  | 755 |  |  | 2,151 |  |  | 2,293 |
Total Revenues | $ | 47,899 |  |  | $ | 46,484 |  |  | $ | 144,206 |  |  | $ | 134,120 |
Operating profit |  |  |  |  |  |  |
Distribution Solutions (2) | $ | 906 |  |  | $ | 803 |  |  | $ | 2,742 |  |  | $ | 2,333 |
Technology Solutions (3) | 122 |  |  | 112 |  |  | 426 |  |  | 305 |
Total | 1,028 |  |  | 915 |  |  | 3,168 |  |  | 2,638 |
Corporate Expenses, Net | (95 | ) |  | (103 | ) |  | (320 | ) |  | (317 | )
Interest Expense | (87 | ) |  | (93 | ) |  | (267 | ) |  | (284 | )
Income from Continuing Operations Before Income Taxes | $ | 846 |  |  | $ | 719 |  |  | $ | 2,581 |  |  | $ | 2,037 |
(1) | Revenues derived from services represent less than 2% of this segment’s total revenues.
(2) | Distribution Solutions operating profit for the third quarter and first nine months of 2016 include $33 million and $215 million in pre-tax charges related to our last-in, first-out (“LIFO”) method of accounting for inventories. The third quarter and first nine months of 2015 include pre-tax LIFO charges of $95 million and $287 million. LIFO expense for the third quarter of 2016 includes a gross charge of $65 million, partially offset by a $32 million reversal of a portion of the LIFO expense recorded in the first half of 2016 due to a change in estimate. LIFO expense was less in 2016 primarily due to lower full year expectations for price increases. The third quarter and first nine months of 2016 include $17 million and $76 million of net cash proceeds representing our share of net settlements of antitrust class action lawsuits against drug manufacturers. Additionally, the first nine months of 2016 include a pre-tax gain of $52 million recognized from the sale of our ZEE Medical business.
(3) | Technology Solutions operating profit for the first nine months of 2016 includes a pre-tax gain of $51 million recognized from the sale of our nurse triage business, and for the first nine months of 2015 includes a non-cash pre-tax charge of $34 million related to the retained workforce business within our International Technology business.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8813-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8736-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration